Renal disorder
Not yet recruitingStudy of Surovatamig and Human IgG4 Kappa Monoclonal Antibody Against CD3 and CD19 in Adults with Antibody-Mediated Kidney Disease
Study of Surovatamig and Human IgG4 Kappa Monoclonal Antibody Against CD3 and CD19 in Adults with Antibody-Mediated Kidney Disease
- Disease:Renal disorder
- Substances:Human Igg4 Kappa Monoclonal Antibody Against Cd3 And Cd19
Belgium- Participants:18–64 years · 65+ years
- Substances:Human Igg4 Kappa Monoclonal Antibody Against Cd3 And Cd19
- Sponsor:AstraZeneca AB







